Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

SHE:300181 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	11,805	10,545	7,477	7,484	7,097	3,591
Market Cap Growth	12.77%	41.03%	-0.09%	5.46%	97.63%	16.83%
Enterprise Value	11,841	10,199	6,742	7,536	7,203	3,829
Last Close Price	17.03	14.80	9.98	9.77	10.41	5.20
PE Ratio	19.89	20.77	19.52	27.41	39.56	40.44
Forward PE	18.41	61.41	61.41	61.41	61.41	61.41
PS Ratio	4.20	4.09	3.85	4.15	4.87	3.29
PB Ratio	3.71	3.74	2.70	2.71	3.58	2.09
P/TBV Ratio	4.07	4.11	2.96	2.98	4.30	2.56
P/FCF Ratio	417.18	308.69	47.70	53.24	68.34	16.22
P/OCF Ratio	33.83	35.50	25.92	23.49	28.18	12.84
EV/Sales Ratio	4.21	3.96	3.47	4.18	4.94	3.51
EV/EBITDA Ratio	14.84	15.51	13.95	19.92	25.92	22.35
EV/EBIT Ratio	16.38	17.27	15.99	23.43	32.12	32.60
EV/FCF Ratio	418.43	298.56	43.01	53.62	69.37	17.30
Debt / Equity Ratio	0.21	0.15	0.08	0.06	0.10	0.20
Debt / EBITDA Ratio	0.83	0.65	0.46	0.45	0.73	2.03
Debt / FCF Ratio	23.41	12.58	1.42	1.23	1.99	1.57
Asset Turnover	0.66	0.68	0.53	0.56	0.56	0.48
Inventory Turnover	2.27	2.14	1.65	1.81	1.77	1.80
Quick Ratio	1.42	1.52	2.04	2.16	1.13	1.05
Current Ratio	1.86	2.06	2.59	2.60	1.61	1.61
Return on Equity (ROE)	20.83%	18.45%	14.12%	12.04%	10.37%	6.10%
Return on Assets (ROA)	10.61%	9.69%	7.25%	6.29%	5.37%	3.25%
Return on Invested Capital (ROIC)	19.95%	23.44%	19.66%	15.19%	10.63%	6.07%
Return on Capital Employed (ROCE)	21.50%	20.10%	14.90%	11.10%	10.40%	6.30%
Earnings Yield	5.05%	4.82%	5.12%	3.65%	2.53%	2.47%
FCF Yield	0.24%	0.32%	2.10%	1.88%	1.46%	6.16%
Dividend Yield	3.53%	4.05%	4.51%	3.07%	1.92%	1.92%
Payout Ratio	72.10%	63.18%	55.65%	53.17%	39.17%	34.80%
Buyback Yield / Dilution	-0.12%	0.10%	-14.76%	1.93%	-1.64%	-0.12%
Total Shareholder Return	3.40%	4.15%	-10.25%	5.01%	0.28%	1.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.